The probability of relapse and disability progression during pregnancy was associated with time when natalizumab was stopped and number of relapses in the year before natalizumab treatment.
from Front page feed https://ift.tt/3eJiJM2
from Front page feed https://ift.tt/3eJiJM2
Comments
Post a Comment